Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive functions. Today the diagnosis of AD relies on clinical evaluations and is only late in the disease. Biomarkers for early detection of the underlying neuropathological changes are still lacki...

Full description

Bibliographic Details
Main Authors: Christian Czech, Peter Berndt, Kristina Busch, Oliver Schmitz, Jan Wiemer, Veronique Most, Harald Hampel, Jürgen Kastler, Hans Senn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3281064?pdf=render